Scalable Process for High-Yield Production of PfCyRPA Using Insect Cells for Inclusion in a Malaria Virosome-Based Vaccine Candidate

Plasmodium falciparum cysteine-rich protective antigen (PfCyRPA) has been identified as a promising blood-stage candidate antigen to include in a broadly cross-reactive malaria vaccine. In the last couple of decades, substantial effort has been committed to the development of scalable cost-effective...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandes, Bárbara, Sousa, Marcos, Castro, Rute, Schäfer, Anja, Hauser, Julia, Schulze, Kai, Amacker, Mario, Tamborrini, Marco, Pluschke, Gerd, Alves, Paula M, Fleury, Sylvain, Roldão, António
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163744/
https://www.ncbi.nlm.nih.gov/pubmed/35669054
http://dx.doi.org/10.3389/fbioe.2022.879078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163744/
https://www.ncbi.nlm.nih.gov/pubmed/35669054
http://dx.doi.org/10.3389/fbioe.2022.879078

Ejemplares similares